Trevi Therapeutics, Inc.

By person

32 insiders · 114 transactions

5.4×

Jennifer Good holds 5.4 times base salary in stock. $3.39M of shares against $622.38K in salary for 2025.

Salary from the company's own proxy. The shares are what Jennifer Good last reported holding, valued at $15.88, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Behbahani Ali

10% owner

$31.80M (5)

$1.50K (1) scheduled

+$31.80M

11,325,508

7.95%

$179.85M

—

Chang Carmen

10% owner

$31.80M (5)

$1.50K (1) scheduled

+$31.80M

11,325,508

7.95%

$179.85M

—

Florence Anthony A. Jr.

10% owner

$31.80M (5)

$1.50K (1) scheduled

+$31.80M

11,325,508

7.95%

$179.85M

—

Makhzoumi Mohamad

10% owner

$31.80M (5)

$1.50K (1) scheduled

+$31.80M

11,325,508

7.95%

$179.85M

—

SANDELL SCOTT D

10% owner

$31.80M (5)

$1.50K (1) scheduled

+$31.80M

11,325,508

7.95%

$179.85M

—

Sonsini Peter W.

10% owner

$31.80M (5)

$1.50K (1) scheduled

+$31.80M

11,325,508

7.95%

$179.85M

—

Walker Paul Edward

10% owner

$31.80M (5)

$1.50K (1) scheduled

+$31.80M

11,325,508

7.95%

$179.85M

—

BASKETT FOREST

10% owner

$30.00M (4)

$1.50K (1) scheduled

+$30.00M

20,797,988

14.60%

$330.27M

+100.4%

New Enterprise Associates 16, L.P. entity

10% owner

$30.00M (4)

$1.50K (1) scheduled

+$30.00M

10,421,428

7.31%

$165.49M

—

BARRIS PETER J

10% owner

$25.00M (2)

—

+$25.00M

4,438,562

3.12%

$70.48M

—

MOTT DAVID M

10% owner

$25.00M (2)

—

+$25.00M

4,438,562

3.12%

$70.48M

—

MAKOWER JOSHUA

10% owner

$25.00M (2)

$1.50K (1) scheduled

+$25.00M

10,376,560

7.28%

$164.78M

+133.8%

TPG Group Holdings (SBS) Advisors, Inc. entity

10% owner

$8.00M (1)

—

+$8.00M

4,824,883

3.39%

$76.62M

—

Omega Fund V, L.P. entity

10% owner

$4.81M (1)

—

+$4.81M

1,063,408

0.7464%

$16.89M

—

Agger Mette Kirstine

Director

$3.75M (1)

—

+$3.75M

1,151,544

0.8082%

$18.29M

—

Lundbeckfond Invest A/S

10% owner

$3.75M (1)

—

+$3.75M

1,151,544

0.8082%

$18.29M

—

TPG GP A, LLC entity

Former 10% Owner

—

$2.83M (7)

−$2.83M

3,824,883

2.68%

$60.74M

−20.7%

Aperture Venture Partners IV, L.P. entity

10% owner

$1.12M (1)

—

+$1.12M

344,963

0.2421%

$5.48M

—

Mellon Family Investment Co V entity

10% owner

$1.00M (1)

—

+$1.00M

347,156

0.2437%

$5.51M

—

Richard King Mellon Foundation entity

10% owner

$1.00M (1)

—

+$1.00M

347,157

0.2437%

$5.51M

—

Heffernan Michael Thomas

Director

$25.00K (1)

$595.81K (4) scheduled

−$570.81K

6,351

0.0045%

$100.85K

—

Simon Farrell

Chief Commercial Officer

—

$548.88K (2) scheduled

−$548.88K

76,900

0.0540%

$1.22M

+272.4%

SCIASCIA THOMAS

Chief Scientific Officer

—

$289.58K (6) scheduled

−$289.58K

221,373

0.1554%

$3.52M

+11.7%

GOOD JENNIFER L

President & CEO

$112.50K (1)

$308.04K (8) scheduled

−$195.54K

213,313

0.1497%

$3.39M

+16.1%

Meeker David P

Director

$112.50K (1)

$13.35K (1) scheduled

+$99.15K

1,021,696

0.7171%

$16.22M

+52.7%

VANLENT ANNE

Director

$50.00K (1)

—

+$50.00K

25,983

0.0182%

$412.61K

—

Delfini Lisa

Chief Financial Officer

—

$44.96K (10) scheduled

−$44.96K

64,660

0.0454%

$1.03M

+320.5%

Mathers Edward T

Director

—

948,948

0.6660%

$15.07M

—

OSHEA WILLIAM J

10% owner

—

114,080

0.0801%

$1.81M

+658.8%

DRAKE PETER F

10% owner

—

62,540

0.0439%

$993.14K

—

Drake Debra A

10% owner

—

62,540

0.0439%

$993.14K

—

Galletta Christopher

See Remarks

—

26,095

0.0183%

$414.39K

+279.8%

Trevi Therapeutics, Inc.

By person

Individual transactions

What was left out